---
figid: PMC4386974__bph0172-1947-f1
figlink: /pmc/articles/PMC4386974/figure/fig01/
number: Figure 1
caption: 'Simplified schematic presentation of the cytosolic signalling pathways that
  converge to prevent mitochondrial permeability transition pore (MPTP) opening in
  cardioprotection. eNOS/PGK: the nitric oxide-dependent GPCR–eNOS–PKG pathway; RISK:
  the reperfusion-injury salvage kinase pathway based upon PKB, PI3K-Akt and GSK3ß;
  and SAFE: the survivor activating factor enhancement signalling pathway involving
  the JAK-STAT system and TNF-α receptors. Proteins implicated in MPTP formation include
  the matrix cyclophilin D (CyD), the inner membrane adenine nucleotide translocase
  and the outer membrane voltage-dependent anion channel. Additional proteins such
  as the translocator protein 18 kDa (TSPO), located in the outer mitochondrial membrane,
  interact with proteins involved in MPTP formation. Under pathophysiological conditions,
  such as high Ca2+ concentration and increased oxidative stress, the complex forms
  an open pore between the inner and outer membranes that ultimately results in mitochondrial
  swelling, mitochondrial Ca2+ efflux and the release of apoptogenic proteins. Cyclosporin
  A targets matrix CyD, where Ca2+ overload triggers MPTP opening. TRO40303 binds
  to TSPO in the outer membrane. Other abbreviations: eNOS, endothelial nitric oxide
  synthase; GFR, growth factor receptors (insulin-like growth factor-1 and fibroblast
  growth factor-2); GSK3ß, glycogen synthase kinase 3ß; IMM, inner mitochondrial membrane;
  OMM, outer mitochondrial membrane; TNF-R, tumour necrosis factor receptor.'
pmcid: PMC4386974
papertitle: 'Remote conditioning the heart overview: translatability and mechanism.'
reftext: Michael Rahbek Schmidt, et al. Br J Pharmacol. 2015 Apr;172(8):1947-1960.
pmc_ranked_result_index: '134847'
pathway_score: 0.9530998
filename: bph0172-1947-f1.jpg
figtitle: Simplified schematic presentation of the cytosolic signalling pathways that
  converge to prevent mitochondrial permeability transition pore (MPTP) opening in
  cardioprotection
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4386974__bph0172-1947-f1.html
  '@type': Dataset
  description: 'Simplified schematic presentation of the cytosolic signalling pathways
    that converge to prevent mitochondrial permeability transition pore (MPTP) opening
    in cardioprotection. eNOS/PGK: the nitric oxide-dependent GPCR–eNOS–PKG pathway;
    RISK: the reperfusion-injury salvage kinase pathway based upon PKB, PI3K-Akt and
    GSK3ß; and SAFE: the survivor activating factor enhancement signalling pathway
    involving the JAK-STAT system and TNF-α receptors. Proteins implicated in MPTP
    formation include the matrix cyclophilin D (CyD), the inner membrane adenine nucleotide
    translocase and the outer membrane voltage-dependent anion channel. Additional
    proteins such as the translocator protein 18 kDa (TSPO), located in the outer
    mitochondrial membrane, interact with proteins involved in MPTP formation. Under
    pathophysiological conditions, such as high Ca2+ concentration and increased oxidative
    stress, the complex forms an open pore between the inner and outer membranes that
    ultimately results in mitochondrial swelling, mitochondrial Ca2+ efflux and the
    release of apoptogenic proteins. Cyclosporin A targets matrix CyD, where Ca2+
    overload triggers MPTP opening. TRO40303 binds to TSPO in the outer membrane.
    Other abbreviations: eNOS, endothelial nitric oxide synthase; GFR, growth factor
    receptors (insulin-like growth factor-1 and fibroblast growth factor-2); GSK3ß,
    glycogen synthase kinase 3ß; IMM, inner mitochondrial membrane; OMM, outer mitochondrial
    membrane; TNF-R, tumour necrosis factor receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - MAPK3
  - TYK2
  - PIK3CD
  - MAPK1
  - PRKCB
  - PRKD3
  - STAT3
  - PRKCG
  - AKT3
  - PRKCD
  - JAK3
  - PRKCZ
  - NOS3
  - PIK3R4
  - JAK1
  - RAPGEF5
  - NMUR1
  - GSK3B
  - PRKCA
  - JAK2
  - PRKCE
  - PRKCH
  - GSK3A
  - PIK3CA
  - PIK3R6
  - PIK3R5
  - GJA1
  - TNFRSF1A
  - PIK3R3
  - PIK3CG
  - AKT2
  - PRKCI
  - PRKCQ
  - AKT1
  - MPTP
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: GFR
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Cx43
  symbol: CX43
  source: hgnc_alias_symbol
  hgnc_symbol: GJA1
  entrez: '2697'
- word: TNF-R
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: MPTP
  source: MESH
  identifier: D015632
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
